A-Rod hits headlines in troubling report

A-Rod hits headlines in troubling report
April 13, 2013, 6:15 pm
Share This Post

As if the Yankees already couldn’t wait to rid themselves of Alex Rodriguez and his onerous contract, the latest news about the injured third baseman can only make them wish even more they could just cut him loose.

The New York Times reports that a representative of Rodriguez purchased records from the South Florida anti-aging clinic alleged to have provided performance-enhancing drugs to A-Rod and other major-leaguers for the purpose of keeping the information away from Major League Baseball.

Through a spokesman, Rodriguez denied having arranged to buy documents from the clinic, the now-closed Biogenesis.

Though Rodriguez has admitted using steroids earlier in his career — and tried to partially blame his actions on being young — allegations about substances like human growth hormone from Biogenesis cover recent seasons.

Rodriguez, 37, is recovering from off-season hip surgery and coming off a year that ended with his being benched in the postseason because of his lack of production — including the decisive Game 5 of the American League Division Series against the Orioles. The Yankees are only halfway through his ludicrous, 10-year, $275 million contract.

As the Times wrote: “Although the Yankees would never publicly say so, Rodriguez is now widely perceived as a diminished player whose contract is weighing down the team and limiting its flexibility. But he has made clear that he intends to keep playing, and if he is able to do so, the Yankees will have to keep paying him.”